Provided by Tiger Trade Technology Pte. Ltd.

Precipio, Inc.

29.80
-1.9500-6.14%
Post-market: 29.800.00000.00%16:10 EDT
Volume:50.36K
Turnover:1.53M
Market Cap:53.15M
PE:-131.77
High:31.75
Open:31.19
Low:29.14
Close:31.75
52wk High:32.40
52wk Low:5.74
Shares:1.78M
Float Shares:1.45M
Volume Ratio:1.00
T/O Rate:3.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2262
EPS(LYR):-0.2262
ROE:-2.72%
ROA:-3.92%
PB:3.65
PE(LYR):-131.77

Loading ...

Company Profile

Company Name:
Precipio, Inc.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
66
Office Location:
4 Science Park,3rd Floor,New Haven,Connecticut,United States
Zip Code:
06511
Fax:
- -
Introduction:
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

Directors

Name
Position
Ilan Danieli
Chief Executive Officer and Director
Richard Sandberg
Chairman of the Board and Director
Christina Valauri
Independent Director
David Cohen
Independent Director
Jeffrey Cossman
Independent Director
Kathleen LaPorte
Independent Director
Ronald Andrews
Independent Director

Shareholders

Name
Position
Ilan Danieli
Chief Executive Officer and Director
Ahmed Zaki Sabet
Chief Operating Officer
Matthew Gage
Chief Financial Officer
Ayman Mohamed
Chief Technology Officer